Daiichi Sankyo scores first nod for IV iron replacement drug in patients with heart failure
Daiichi Sankyo is expanding the label of its iron replacement injectable, Injectafer, into a first-of-its-kind indication, according to the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
